This paper from TransCelerate BioPharma Inc. considers how de-identification and anonymization techniques can be applied to individual patient data in order to fulfill transparency, disclosure and research requests while safeguarding the privacy of individuals (e.g., participants and company staff). This paper proposes which techniques to apply in order to conform to existing directives and regulatory guidance while balancing the utility of the de-identified data to the researcher.
Data De-identification and Anonymization of Individual Patient Data in Clinical Studies — A Model Approach
A Visual Guide to Practical Data De-Identification
This infographic, produced by the Future of Privacy Forum, serves as an introductory guide to data de-identification and how to distinguish between different categories of data....
The De-identification Maturity Model
This white paper from Privacy Analytics looks at their development of the “De-identification Maturity Model” as a formal framework for evaluating the maturity of anonymization services within an organization. The framework gauges the level of an organization’s readiness and experience with respect t...